1625 Unity NW Way Winter Haven, FL 33881-2107
This exceptional investment opportunity presents a 6,416 square foot medical office building in Winter Haven, Florida, fully occupied by DaVita Dialysis under a modified triple-net (NNN) lease. The lease, guaranteed by DaVita Inc., a Fortune 500 company, boasts a remaining term of 7.4 years with two, five-year renewal options and a 10% rent increase every five years. The property, built in 1996 and extensively renovated in 2024, sits on a 0.81-acre lot and features one single-story building. The current annual net operating income (NOI) is $140,580, representing a 6.25% cap rate and a price per square foot of $350.57. The asking price is $2,249,280. Significant recent renovations, estimated at $433,000, included tenant improvements, HVAC replacement, plumbing and electrical upgrades, and parking lot repairs. The property enjoys a prime location near Highway 17, with high daily traffic counts, and benefits from strong demographics, including proximity to Winter Haven Hospital and LEGOLAND Florida. This offering provides a secure, long-term investment with a resilient tenant in a thriving Central Florida market. The lease's corporate guarantee and built-in rent escalations offer significant financial stability and growth potential. This is an ideal opportunity for investors seeking a low-risk, high-return investment in the healthcare sector.
-
DaVita Winter Haven Dialysis Medical Clinic
-
Davita Winter Haven Physician
Cap rate
Implied · in-place · derived from last sale + estimated NOIValue
AI, CAP & Alternative Use estimations · Realmo proprietary blendProperty tax & assessments
Tax year 2023Comparables
6 recent transactions · within 1.5 miComparable in this City
Similar Nearby for Sale
Similar Nearby for Lease
Property description
Physical attributes from public recordsZoning & alternative use
Costs & Benchmarks
Operating expenses, capex projections, utility benchmarks, and submarket comparables — all in one view.
Risks
Flood, climate, environmental, title, and tenant-concentration risk — surfaced with mitigations and source citations.